On July 27, 2023, Cutera, Inc. announced that Talyor C. Harris had been appointed as the company?s president, effective as of his first day of employment, which is expected to be August 7, 2023. Mr. Harris has served as a member of the Board of Directors of the Company since May 2023. Mr. Harris served as the Chief Financial Officer for MyoKardia, Inc. from April 2018 until that company?s acquisition by Bristol Myers Squibb in November 2020.

Prior to that, Mr. Harris served as Senior Vice President and Chief Financial Officer of Zeltiq Aesthetics, Inc., until that company?s acquisition by Allergan plc. He also served as Vice President and Chief Financial Officer at Thoratec Corporation, which was eventually acquired by St. Jude Medical, Inc. and worked at JPMorgan Chase & Co.

for over a decade in several capacities, including as a Vice President in the firm?s Healthcare Investment Banking and Equity Research departments. Mr. Harris currently serves on the board of PROCEPT BioRobotics, Omada Health and Endologix. He previously served on the board of HealthCor Catalio Acquisition Corp.

Mr. Harris holds a B.A. from the University of North Carolina at Chapel Hill.